10.1016j.ydbio.2007.03.004.ann

T1 Condition 1176 1181 tumor
T2 Condition 412 417 tumor
T3 Protein 473 483 apelin-APJ
T4 Organism 801 816 Xenopus embryos
T7 Condition 1008 1025 malignant gliomas
T8 Gene 837 840 APJ
T9 Intervention 70 75 blood
T10 Gene 915 918 APJ
T11 Intervention 97 107 body fluid
T13 Level 705 754 non-mitogenic for primary human endothelial cells
T14 Condition 987 999 brain tumors
T15 Gene 286 291 genes
T16 Gene 423 428 genes
T17 Condition 993 998 tumor
T18 Protein 875 880 VEGFA
T19 Condition 275 280 tumor
T20 Protein 510 529 intersomitic vessel
T21 Gene 1063 1066 APJ
T22 Gene 15 45 G protein-coupled receptor APJ
T23 Gene 676 681 genes
T24 Protein 629 634 VEGFA
T25 Protein 1171 1198 anti-tumor angiogenic drugs
T26 Protein 801 808 Xenopus
T27 Protein 191 201 apelin-APJ
T28 Protein 830 840 apelin-APJ
T29 Intervention 955 983 microvascular proliferations
T30 Gene 535 540 genes
T32 Gene 591 627 vascular endothelial growth factor A
T33 Protein 453 460 Xenopus
T34 Condition 229 238 embryonic
T35 Condition 398 407 embryonic
T36 Gene 1070 1075 genes
R1 Relation Arg1:T19 Arg2:T15
R2 Relation Arg1:T34 Arg2:T15
R3 Relation Arg1:T34 Arg2:T19